QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
OTCMKTS:CAPS

Capstone Therapeutics (CAPS) Stock Forecast, Price & News

$7.50
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$7.50
▼
$7.50
50-Day Range
$7.50
▼
$7.50
52-Week Range
$5.00
▼
$20.00
Volume
2 shs
Average Volume
150 shs
Market Capitalization
$600,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsHeadlinesSEC Filings

CAPS stock logo

About Capstone Therapeutics (OTCMKTS:CAPS) Stock

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

CAPS Price History

CAPS Stock News Headlines

August 28, 2023 | finanznachrichten.de
Capstone Therapeutics Corp: Capstone Holding Corp. Announces CFO Change
August 28, 2023 | finance.yahoo.com
Capstone Holding Corp. Announces CFO Change
September 25, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
May 17, 2023 | nasdaq.com
Capstone Green Energy Corporation Common Stock (CGRN)
February 19, 2023 | bizjournals.com
Dobbins, Capstone developing apartment complex in Florida
February 15, 2023 | finance.yahoo.com
Capstone Copper Reports Fourth Quarter and Full-Year 2022 Financial Results
December 29, 2022 | marketwatch.com
Student Premium Private Hostels, Studios and Housing Market (New Report) 2023 Is Flourishing Around the World by 2029 | 127 Pages Report
September 18, 2022 | uk.finance.yahoo.com
Global Head and Neck Cancer Therapeutics Market Report 2022: Advances in Biochemistry and Genomics Fuels Sector
September 25, 2023 | Edge On The Street (Ad)
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
September 15, 2022 | finance.yahoo.com
CapStone Holdings Inc. and Gamers Outreach Bring Gaming to Children's Hospitals in St. Louis
September 15, 2022 | reuters.com
Capstone Therapeutics Corp
September 9, 2022 | yahoo.com
Hormel Foods announces free downtown concert
September 7, 2022 | stockhouse.com
ADC Therapeutics to Participate in Morgan Stanley's 20th Annual Global Healthcare Conference
August 19, 2022 | nz.finance.yahoo.com
Kriya Appoints Pedro Huertas M.D., Ph.D., as Chief Medical Officer of its Rare Disease Division
July 12, 2022 | uk.finance.yahoo.com
Max Q: Grounded
June 21, 2022 | finanznachrichten.de
Capstone Therapeutics Corp: Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder,
May 21, 2022 | yahoo.com
Everything you need to know about NASA’s historic CAPSTONE launch
March 16, 2022 | insidermonkey.com
10 Stocks to Buy Now According to Leonard A. Potter’s Wildcat Capital Management
March 15, 2022 | finance.yahoo.com
Capstone To Provide Resilient Power System For New Plant In Maryland
March 15, 2022 | seekingalpha.com
Capstone Green Energy to provide power system for Maryland cell therapy plant
February 26, 2022 | finanznachrichten.de
Capstone Therapeutics Corp. Announces Name Change to Capstone Holding Corp.
December 2, 2021 | finance.yahoo.com
Capstone Therapeutics Corp. Announces Results of Annual Meeting
December 1, 2021 | uk.finance.yahoo.com
MANA Therapeutics Announces Final Closing of Series A and Closing of Venture Debt Facility
August 25, 2021 | baystreet.ca
Stocks Build on Gains
August 23, 2021 | nasdaq.com
Canadian Market Firmly Up In Positive Territory; Trillium Therapeutics Skyrockets
August 18, 2021 | msn.com
New 130K square-foot drug manufacturing plant in Seattle area will develop COVID-19 therapeutics
August 10, 2021 | sg.finance.yahoo.com
Capstone Infrastructure Corporation Reports Second Quarter Results And Declares A Quarterly Dividend
See More Headlines
Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CAPS Company Calendar

Last Earnings
8/13/2018
Today
9/25/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CAPS
CUSIP
N/A
CIK
887151
Web
www.capstonethx.com
Phone
(708) 371-0660
Fax
602-286-5300
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
80,000
Free Float
45,000
Market Cap
$600,000.00
Optionable
Not Optionable
Beta
131.81
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael M. Toporek (Age 57)
    CEO, Pres & Chairman
  • Edward Schultz
    VP,CFO & Treasurer
  • Mr. Matthew E. Lipman (Age 44)
    VP, Sec. & Director

Key Competitors

View All Competitors













CAPS Stock - Frequently Asked Questions

How have CAPS shares performed in 2023?

Capstone Therapeutics' stock was trading at $37.00 at the beginning of 2023. Since then, CAPS shares have decreased by 79.7% and is now trading at $7.50.
View the best growth stocks for 2023 here.

How were Capstone Therapeutics' earnings last quarter?

Capstone Therapeutics Corp. (OTCMKTS:CAPS) posted its quarterly earnings data on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share for the quarter. The biotechnology company had revenue of $2 million for the quarter.

What other stocks do shareholders of Capstone Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Capstone Therapeutics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).

What is Capstone Therapeutics' stock symbol?

Capstone Therapeutics trades on the OTCMKTS under the ticker symbol "CAPS."

How do I buy shares of Capstone Therapeutics?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Capstone Therapeutics' stock price today?

One share of CAPS stock can currently be purchased for approximately $7.50.

How much money does Capstone Therapeutics make?

Capstone Therapeutics (OTCMKTS:CAPS) has a market capitalization of $600,000.00.

How can I contact Capstone Therapeutics?

Capstone Therapeutics' mailing address is 1275 W. Washington Street Suite 104, Tempe AZ, 85281. The official website for the company is www.capstonethx.com. The biotechnology company can be reached via phone at (708) 371-0660, via email at investorinquiries@capstonethx.com, or via fax at 602-286-5300.

This page (OTCMKTS:CAPS) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -